Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1998 1
2000 1
2001 2
2005 1
2006 1
2010 2
2011 4
2012 3
2013 2
2014 5
2015 2
2016 4
2017 11
2018 14
2019 18
2020 14
2021 23
2022 23
2023 16
2024 19

Text availability

Article attribute

Article type

Publication date

Search Results

151 results

Results by year

Filters applied: . Clear all
Page 1
Tuberculosis.
Ankrah AO, Glaudemans AWJM, Maes A, Van de Wiele C, Dierckx RAJO, Vorster M, Sathekge MM. Ankrah AO, et al. Among authors: sathekge mm. Semin Nucl Med. 2018 Mar;48(2):108-130. doi: 10.1053/j.semnuclmed.2017.10.005. Epub 2017 Nov 16. Semin Nucl Med. 2018. PMID: 29452616 Review.
Letter from the Editors.
Bouchelouche K, Sathekge MM. Bouchelouche K, et al. Among authors: sathekge mm. Semin Nucl Med. 2024 Sep;54(5):635-637. doi: 10.1053/j.semnuclmed.2024.08.001. Semin Nucl Med. 2024. PMID: 39155087 No abstract available.
Letter from the Editors.
Bouchelouche K, Sathekge MM. Bouchelouche K, et al. Among authors: sathekge mm. Semin Nucl Med. 2024 May;54(3):311-312. doi: 10.1053/j.semnuclmed.2024.04.002. Epub 2024 Apr 26. Semin Nucl Med. 2024. PMID: 38670819 No abstract available.
Letter from the Editors.
Sathekge MM, Bouchelouche K. Sathekge MM, et al. Semin Nucl Med. 2023 Jul;53(4):467-468. doi: 10.1053/j.semnuclmed.2023.05.001. Epub 2023 May 13. Semin Nucl Med. 2023. PMID: 37188566 No abstract available.
Letter from the Editors.
Bouchelouche K, Sathekge MM. Bouchelouche K, et al. Among authors: sathekge mm. Semin Nucl Med. 2023 Sep;53(5):555-557. doi: 10.1053/j.semnuclmed.2023.06.008. Epub 2023 Jul 13. Semin Nucl Med. 2023. PMID: 37451935 No abstract available.
Letter from the Editors.
Sathekge MM, Bouchelouche K. Sathekge MM, et al. Semin Nucl Med. 2023 Jan;53(1):1-3. doi: 10.1053/j.semnuclmed.2022.11.002. Semin Nucl Med. 2023. PMID: 36460419 No abstract available.
Letter From the Editors.
Sathekge MM, Bouchelouche K. Sathekge MM, et al. Semin Nucl Med. 2023 Nov;53(6):731-732. doi: 10.1053/j.semnuclmed.2023.09.001. Epub 2023 Sep 21. Semin Nucl Med. 2023. PMID: 37739849 No abstract available.
Actinium-225-PSMA radioligand therapy of metastatic castration-resistant prostate cancer (WARMTH Act): a multicentre, retrospective study.
Sathekge MM, Lawal IO, Bal C, Bruchertseifer F, Ballal S, Cardaci G, Davis C, Eiber M, Hekimsoy T, Knoesen O, Kratochwil C, Lenzo NP, Mahapane J, Maserumule LC, Mdlophane AH, Mokoala KMG, Ndlovu H, Pant V, Rathke H, Reed J, Sen IB, Singh A, Sood A, Tauber R, Thakral P, Yadav MP, Morgenstern A. Sathekge MM, et al. Lancet Oncol. 2024 Feb;25(2):175-183. doi: 10.1016/S1470-2045(23)00638-1. Epub 2024 Jan 11. Lancet Oncol. 2024. PMID: 38218192
Letter From the Editors.
Bouchelouche K, Sathekge MM. Bouchelouche K, et al. Among authors: sathekge mm. Semin Nucl Med. 2024 Jan;54(1):1-3. doi: 10.1053/j.semnuclmed.2023.11.006. Semin Nucl Med. 2024. PMID: 38065626 No abstract available.
Letter from the Editors.
Sathekge MM, Bouchelouche K. Sathekge MM, et al. Semin Nucl Med. 2024 Jul;54(4):457-459. doi: 10.1053/j.semnuclmed.2024.06.004. Epub 2024 Jul 6. Semin Nucl Med. 2024. PMID: 38972759 No abstract available.
151 results